FDA Clearance Tracker · P840064-S062
VISCOAT OPHTHALMIC VISCOSURGICAL DEVICE; DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE (WITH PROVISC IN LATEX-FREE PACK)
Last checked: Nov 20, 2026Latest source record: Oct 31, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Oct 31, 2017
Approved
Time to decision
467 days
Received Jul 21, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P840064-S062
- Device name
- VISCOAT OPHTHALMIC VISCOSURGICAL DEVICE; DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE (WITH PROVISC IN LATEX-FREE PACK)
- Applicant
- Alcon Laboratories
- Applicant location
- Fort Worth, TX
- Received
- Jul 21, 2016
- Decided
- Oct 31, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P840064
Device type
- Device type
- AID, SURGICAL, VISCOELASTIC (LZP)
- Device class
- Class III
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site change located at Lifecore Biomedical, LLC., 3515 Lyman Boulevard, Chaska, Minnesota, USA, and Lifecore Biomedical, LLC, 1245 Lakeview Drive, Chaska, Minnesota, USA.
Source documents
Other decisions for Alcon Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K252682 · Decided Sep 24, 2025 · 30 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K243896 · Decided Apr 28, 2025 · 131 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.